The role of preeclampsia in breast cancer risk: insights from Mendelian randomization study

被引:0
|
作者
Qian, Chenfei [1 ]
Xiong, Ganwei [2 ]
Hong, Shihao [3 ]
Miao, Linzhe [1 ]
Guo, Yitao [1 ,4 ]
机构
[1] Zhejiang Hosp, Hangzhou 310013, Peoples R China
[2] First Peoples Hosp Xiushui Cty, Jiujiang 332400, Peoples R China
[3] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Obstet & Gynecol, Hangzhou 310016, Peoples R China
[4] Zhejiang Hosp, Dept Cardiol, Hangzhou 310013, Peoples R China
关键词
Preeclampsia; Breast cancer; Genome-wide association study; Mendelian randomization; Meta-analysis; ENDOTHELIAL-GROWTH-FACTOR; VEGF EXPRESSION; PREGNANCY; PATHOPHYSIOLOGY; ASSOCIATION; SERUM;
D O I
10.1007/s12672-025-02248-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background The relationship between preeclampsia and breast cancer risk is still debated, with observational studies yielding inconsistent results. This research aims to clarify the causal link between preeclampsia and breast cancer using Mendelian randomization (MR) methods. Methods We utilized genome-wide association study (GWAS) data to identify single nucleotide polymorphisms (SNPs) that are significantly associated with preeclampsia, which served as genetic instruments. A two-sample Mendelian randomization (TSMR) approach was applied, primarily using inverse variance weighting (IVW) to assess the causal impact of preeclampsia on breast cancer risk. To strengthen our findings, a meta-analysis of IVW estimates from both discovery and validation cohorts was performed, complemented by sensitivity analyses to investigate heterogeneity and potential horizontal pleiotropy. Results In the discovery cohort, IVW analysis revealed a potential inverse relationship between preeclampsia and breast cancer risk (OR, 0.971; 95% CI, 0.947-0.996; P = 0.022). However, the validation cohort did not demonstrate a significant causal association (OR, 0.992; 95% CI, 0.975-1.008; P = 0.327). The combined meta-analysis indicated that preeclampsia might be linked to a lower risk of breast cancer (OR, 0.986; 95% CI, 0.972-0.999; P = 0.041). In subgroup analysis, preeclampsia was found to have a potential association only with estrogen receptor (ER)-negative breast cancer (OR, 0.956; 95% CI, 0.916-0.999; P = 0.043), while no significant link was observed with estrogen receptor (ER)-positive breast cancer (OR, 0.972; 95% CI, 0.945-1.000; P = 0.051). Sensitivity analyses indicated no significant heterogeneity or evidence of horizontal pleiotropy (P > 0.05). Conclusion This MR study, supported by a robust meta-analysis, suggests that preeclampsia may have a protective effect against breast cancer, especially ER-negative breast cancer. However, to firmly establish this relationship, additional prospective studies with larger populations are warranted. Moreover, further exploration of the biological mechanisms underlying this potential association is needed through both in vitro and in vivo research.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Breast Cancer and Meningioma Risk: A Mendelian Randomization Study
    Huang, Jian-Wei
    Wang, Yi-Fei
    Hu, Ying-Qing
    He, Hai-Yong
    Gao, Shuang-Qi
    Guo, Ying
    BRAIN AND BEHAVIOR, 2025, 15 (03):
  • [2] Genetic susceptibility to breast cancer increases the risk of neutropenia and agranulocytosis: insights from Mendelian randomization
    Wei, Changlong
    Zhang, Gongyin
    Li, Changwang
    Zeng, Jinsheng
    SUPPORTIVE CARE IN CANCER, 2024, 32 (07)
  • [3] Allergy, asthma, and the risk of breast and prostate cancer: a Mendelian randomization study
    Jiang, Xia
    Dimou, Niki L.
    Zhu, Zhaozhong
    Bonilla, Carolina
    Lewis, Sarah J.
    Lindstrom, Sara
    Kraft, Peter
    Tsilidis, Konstantinos K.
    Martin, Richard M.
    CANCER CAUSES & CONTROL, 2020, 31 (03) : 273 - 282
  • [4] The role of blood metabolites in oral cancer: insights from a Mendelian randomization approach
    Hu, Ziyang
    Xu, Zhe
    Yue, Qu
    Pan, Xuhong
    Shi, Ping
    Zhang, Dandan
    Zhang, Jiexia
    Deng, Runzhi
    Lin, Zitong
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [5] A Mendelian randomization study of the effect of tea intake on breast cancer
    Deng, Yuqing
    Ge, Wenxin
    Xu, Huili
    Zhang, Jiaming
    FRONTIERS IN NUTRITION, 2022, 9
  • [6] Air pollution and breast cancer risk: a Mendelian randomization study
    Cao, Kangdi
    Wang, Jinkun
    Hou, Wei
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL HEALTH RESEARCH, 2025,
  • [7] The Causal Effect of Dietary Composition on the Risk of Breast Cancer: A Mendelian Randomization Study
    Dong, Hao
    Kong, Xiangyi
    Wang, Xiangyu
    Liu, Qiang
    Fang, Yi
    Wang, Jing
    NUTRIENTS, 2023, 15 (11)
  • [8] Sex hormone binding globulin and risk of breast cancer: a Mendelian randomization study
    Dimou, Niki L.
    Papadimitriou, Nikos
    Gill, Dipender
    Christakoudi, Sofia
    Murphy, Neil
    Gunter, Marc J.
    Travis, Ruth C.
    Key, Tim J.
    Fortner, Renee T.
    Haycock, Philip C.
    Lewis, Sarah J.
    Muir, Kenneth
    Martin, Richard M.
    Tsilidis, Konstantinos K.
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2019, 48 (03) : 807 - 816
  • [9] Effects of glutamate and aspartate on prostate cancer and breast cancer: a Mendelian randomization study
    Lin, Yindan
    Yang, Ze
    Li, Jingjia
    Sun, Yandi
    Zhang, Xueyun
    Qu, Zihao
    Luo, Yan
    Zhang, Lihong
    BMC GENOMICS, 2022, 23 (01)
  • [10] Causal pathways in preeclampsia: a Mendelian randomization study in European populations
    Tan, Zilong
    Ding, Mengdi
    Shen, Jianwu
    Huang, Yuxiao
    Li, Junru
    Sun, Aochuan
    Hong, Jing
    Yang, Yan
    He, Sheng
    Pei, Chao
    Luo, Ran
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15